Post by A.Menarini Diagnostics

Advances in onco-urology continue to reshape the way clinicians approach diagnosis and patient management. On 11–12 June, A. Menarini Diagnostics will be in Lille for the Journées d'Onco-Urologie Médicale (JOUM), an important meeting dedicated to innovation and clinical practice in uro-oncology. Within this evolving landscape, diagnostics plays a key role in supporting earlier detection and more informed decision-making throughout the patient pathway. Our team will be present to showcase our non-invasive, urine-based epigenetic biomarker testing in bladder cancer detection and monitoring, and exchange perspectives on current challenges and future directions in onco-urology. 🌍 Lille, France 📅 11-12 June #OncoUrology #Oncology #Urology #bladdercancer #biomarkers #MenariniDiagnostics